{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:25:07Z","timestamp":1793384707718,"version":"4.5.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Transient hyponatremia due to syndrome of inappropriate antidiuresis (SIAD) is a frequent (20-50%) complication of traumatic brain injury (TBI), but it rarely persists or recurs. There are only few published reports of patients suffering from non-transient hyponatremia due to chronic SIAD after TBI. We report two more cases with this condition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case 1<\/jats:title><jats:p>A 36-year-old woman suffering from major depression and treated with olanzapine reported severe TBI after a severe fall. Following head injury, she developed severe hyponatremia, which was managed with fluid restriction and salt supplementation. Upon hospital discharge, 7 months after trauma, mild hyponatremia was still reported (Na 134 mmol\/L), which dropped to severe hyponatremia in a week despite continuation of treatment, and spontaneously returned to normal. Two months later, the patient presented one more episode of moderate hyponatremia without clear triggering events. Pituitary hormones were normal and urinary sodium and urinary and plasma osmolality supported the diagnosis of SIAD. Therefore, tolvaptan 7.5 mg daily was started, with sustained normalization of sodium levels. When olanzapine was stopped, discontinuation of tolvaptan was attempted. However, serum sodium dropped again and tolvaptan had to be resumed, with natremia remaining within normal range at follow-up. Consistently, olanzapine-related hyponatremia could be ruled out and post-traumatic SIAD confirmed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case 2<\/jats:title><jats:p>A 37-year-old man experienced TBI with diffuse axonal injury falling during a mountain trip. Over the following year, he presented two episodes of tonic-clonic seizures accompanied by the biochemical finding of moderate-severe hyponatremia. Hyponatremia resolved following hypertonic (3% NaCl) saline infusion, and valproate treatment was started after the second episode. In the following outpatient visits, a progressive decrease of serum sodium from 141 mmol\/L to 132 mmol\/L was observed, with other tests consistent with SIAD. Therefore, considering the high risk of recurrent seizures as well as the concomitant treatment with valproate, tolvaptan 7.5 mg every other day was started and normal sodium levels have been maintained since then.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We report two cases of recurrent SIAD following TBI, with multiple hyponatremic episodes after initial presentation. This highlights the importance of long-term follow-up of electrolyte abnormalities after head injury.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1536247","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:11:05Z","timestamp":1741237865000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent hyponatremia due to syndrome of inappropriate antidiuresis after traumatic brain injury: two case reports"],"prefix":"10.3389","volume":"16","author":[{"given":"Iulia","family":"Petria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Indirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Lanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2014-1065","article-title":"Pituitary dysfunction after traumatic brain injury: A clinical and pathophysiological approach","volume":"36","author":"Tanriverdi","year":"2015","journal-title":"Endocr Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2476","article-title":"High Risk of Hypopituitarism after Traumatic Brain Injury: A Prospective Investigation of Anterior Pituitary Function in the Acute Phase and 12 Months after Trauma","volume":"91","author":"Tanriverdi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s11102-018-0917-z","article-title":"Posterior pituitary dysfunction following traumatic brain injury: review","volume":"22","author":"Tudor","year":"2019","journal-title":"Pituitary"},{"key":"B4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1139\/bcb-2016-0160","article-title":"Traumatic brain injury: classification, models, and markers","volume":"96","author":"Najem","year":"2018","journal-title":"Biochem Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0504","article-title":"Residual pituitary function after brain injury-induced hypopituitarism: A prospective 12-month study","volume":"90","author":"Aimaretti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1555","article-title":"Acute glucocorticoid deficiency and diabetes insipidus are common after acute traumatic brain injury and predict mortality","volume":"98","author":"Hannon","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-13-1020","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemiaThe guidelines were peer reviewed by the owner societies and by external referees prior to publication","volume":"170","author":"Spasovski","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(03)00004-5","article-title":"Evaluation and management of hypo-osmolality in hospitalized patients","volume":"32","author":"Janicic","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac245","article-title":"Approach to the patient: hyponatremia and the syndrome of inappropriate antidiuresis (SIAD)","volume":"107","author":"Martin-Grace","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2011.03.042","article-title":"Hyponatremia in patients with traumatic brain injury: etiology, incidence, and severity correlation","volume":"76","author":"Lohani","year":"2011","journal-title":"World Neurosurg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/0090-3019(85)90212-5","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone after severe head injury","volume":"23","author":"Born","year":"1985","journal-title":"Surg Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2014.01.010","article-title":"Antidepressants and the risk of hyponatremia: A class-by-class review of literature","volume":"55","author":"De Picker","year":"2014","journal-title":"Psychosomatics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-012-9805-y","article-title":"Hyponatremia and brain injury: historical and contemporary perspectives","volume":"18","author":"Kirkman","year":"2013","journal-title":"Neurocrit Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(01)00007-X","article-title":"Systemic diseases associated with disorders of water homeostasis","volume":"31","author":"Wong","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1058","article-title":"Posterior pituitary dysfunction after traumatic brain injury","volume":"89","author":"Agha","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","article-title":"Persevering syndrome of inappropriate antidiuretic hormone secretion after traumatic brain injury","volume":"78","author":"van der Voort","year":"2020","journal-title":"Neth J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"150070","DOI":"10.1530\/EDM-15-0070","article-title":"Persistent syndrome of inappropriate antidiuretic hormone secretion following traumatic brain injury","volume":"2015","author":"Dick","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-10-200111200-00027","article-title":"Delayed syndrome of inappropriate antidiuretic hormone secretion 1 year after a head injury","volume":"135","author":"Kumar","year":"2001","journal-title":"Ann Intern Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e318149e6f1","article-title":"Recurrent hyponatremia after traumatic brain injury","volume":"335","author":"Chang","year":"2008","journal-title":"Am J Med Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-300576","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone in traumatic brain injury: when tolvaptan becomes a life saving drug","volume":"83","author":"Graziani","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2165\/11532560-000000000-00000","article-title":"Hyponatraemia as an adverse drug reaction of antipsychotic drugs","volume":"33","author":"Mannesse","year":"2010","journal-title":"Drug Saf"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.4088\/JCP.v58n1206c","article-title":"Effects of olanzapine on polydipsia and intermittent hyponatremia","volume":"58","author":"Littrell","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.seizure.2019.10.013","article-title":"Prevalence and risk factors for hyponatremia in adult epilepsy patients: Large-scale cross-sectional cohort study","volume":"73","author":"Yamamoto","year":"2019","journal-title":"Seizure"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2023.1174","article-title":"Valproate-induced severe symptomatic hyponatremia in a patient with schizoaffective disorder: a case study and literature review","volume":"66","author":"Heflin","year":"2023","journal-title":"Eur Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.15171\/jrip.2017.05","article-title":"Severe symptomatic acute hyponatremia in traumatic brain injury responded very rapidly to a single 15 mg dose of oral tolvaptan; a Mayo Clinic Health System hospital experience \u2013 need for caution with tolvaptan in younger patients with preserved renal function","volume":"6","author":"Onuigbo","year":"2017","journal-title":"J Ren Inj Prev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2016.05.002","article-title":"Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys\u00ae Cortisol II assay","volume":"77","author":"Raverot","year":"2016","journal-title":"Ann Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1536247\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:11:07Z","timestamp":1741237867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1536247\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":26,"alternative-id":["10.3389\/fendo.2025.1536247"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1536247","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"article-number":"1536247"}}